Kirsty Flower
Publications by Year
Research Areas
Epigenetics and DNA Methylation, Ovarian cancer diagnosis and treatment, Cancer Immunotherapy and Biomarkers, RNA modifications and cancer, PARP inhibition in cancer therapy
Most-Cited Works
- → Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis(2015)118 cited
- → Stilbenoids remodel the DNA methylation patterns in breast cancer cells and inhibit oncogenic NOTCH signaling through epigenetic regulation of MAML2 transcriptional activity(2016)101 cited
- → Platinum-Based Chemotherapy Induces Methylation Changes in Blood DNA Associated with Overall Survival in Patients with Ovarian Cancer(2016)83 cited
- → Dynamic Chromatin Environment of Key Lytic Cycle Regulatory Regions of the Epstein-Barr Virus Genome(2011)59 cited
- → Clinical Use of Programmed Cell Death-1 and Its Ligand Expression as Discriminatory and Predictive Markers in Ovarian Cancer(2016)51 cited
- → Methylation deregulation of miRNA promoters identifies miR124-2 as a survival biomarker in Breast Cancer in very young women(2018)49 cited
- → Epigenetic Control of Viral Life-Cycle by a DNA-Methylation Dependent Transcription Factor(2011)48 cited
- → The Epstein–Barr virus lytic cycle activator Zta interacts with methylated ZRE in the promoter of host target gene egr1(2009)34 cited
- → Genome-Wide Analyses of Zta Binding to the Epstein-Barr Virus Genome Reveals Interactions in both Early and Late Lytic Cycles and an Epigenetic Switch Leading to an Altered Binding Profile(2012)34 cited
- → Methylation of MYLK3 gene promoter region: a biomarker to stratify surgical care in ovarian cancer in a multicentre study(2017)33 cited